Transcript of virtual press conference with Gregory Hartl, WHO Spokesperson for Global Alert and Response and Dr Marie-Paule Kieny, Director of the Initiative for Vaccine Research, World

First Page		Document Content
Date: 2009-07-14 11:21:03 Vaccination Influenza vaccine Flu pandemic vaccine Influenza FluMist Flu pandemic Malaria vaccine Attenuated vaccine Swine influenza Medicine Health Vaccines		Transcript of virtual press conference with Gregory Hartl, WHO Spokesperson for Global Alert and Response and Dr Marie-Paule Kieny, Director of the Initiative for Vaccine Research, World Add to Reading List Source URL: www.who.int Download Document from Source Website File Size: 51,98 KB Share Document on Facebook

	Frequently asked questions (FAQs) RIA2018SV- Strategic action for the comparison, selection and development of malaria vaccine candidates Document history Version DocID: 1v2j2 - View Document
	1 1 RTS,S/AS01 MALARIA VACCINE CANDIDATE PHASE III SAFETY EVALUATION IN AFRICAN INFANTS 6-12 WEEKS OF AGE AT FIRST VACCINATION OVER FOURTEEN MONTHS OF DocID: 1uoQf - View Document
	ENHANCED PROTECTIVE EFFICACY OF A PLASMODIUM FALCIPARUM MALARIA VACCINE USING A HETEROLOGOUS PRIME-BOOST IMMUNIZATION WITH A BACULOVIRAL DocID: 1tPZr - View Document
	Science article: “Protection Against Malaria by Intravenous Immunization with a Non-Replicating Sporozoite Vaccine” What: A phase 1 clinical trial of Sanaria’s malaria vaccine, the Sanaria PfSPZ Vaccine, demonstrat DocID: 1suvJ - View Document
	Sanaria Inc. to launch crowdfunding campaign for SporoBotTM, a mosquito-dissecting robot for accelerating manufacture of Sanaria’s malaria vaccine. ROCKVILLE, MD – April 30, 2014 – For immediate release - Biotechno DocID: 1sjTZ - View Document